Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Structural basis of sterol recognition by human hedgehog receptor PTCH1.

Qi C, Di Minin G, Vercellino I, Wutz A, Korkhov VM.

Sci Adv. 2019 Sep 18;5(9):eaaw6490. doi: 10.1126/sciadv.aaw6490. eCollection 2019 Sep.

2.

Screening for Factors Involved in X Chromosome Inactivation Using Haploid ESCs.

Monfort A, Di Minin G, Wutz A.

Methods Mol Biol. 2018;1861:1-18. doi: 10.1007/978-1-4939-8766-5_1.

PMID:
30218355
3.

Cell-autonomous and cell non-autonomous downregulation of tumor suppressor DAB2IP by microRNA-149-3p promotes aggressiveness of cancer cells.

Bellazzo A, Di Minin G, Valentino E, Sicari D, Torre D, Marchionni L, Serpi F, Stadler MB, Taverna D, Zuccolotto G, Montagner IM, Rosato A, Tonon F, Zennaro C, Agostinis C, Bulla R, Mano M, Del Sal G, Collavin L.

Cell Death Differ. 2018 Jul;25(7):1224-1238. doi: 10.1038/s41418-018-0088-5. Epub 2018 Mar 22.

4.

HaSAPPy: A tool for candidate identification in pooled forward genetic screens of haploid mammalian cells.

Di Minin G, Postlmayr A, Wutz A.

PLoS Comput Biol. 2018 Jan 16;14(1):e1005950. doi: 10.1371/journal.pcbi.1005950. eCollection 2018 Jan.

5.

Mutant p53 potentiates the oncogenic effects of insulin by inhibiting the tumor suppressor DAB2IP.

Valentino E, Bellazzo A, Di Minin G, Sicari D, Apollonio M, Scognamiglio G, Di Bonito M, Botti G, Del Sal G, Collavin L.

Proc Natl Acad Sci U S A. 2017 Jul 18;114(29):7623-7628. doi: 10.1073/pnas.1700996114. Epub 2017 Jun 30.

6.

Block one, unleash a hundred. Mechanisms of DAB2IP inactivation in cancer.

Bellazzo A, Di Minin G, Collavin L.

Cell Death Differ. 2017 Jan;24(1):15-25. doi: 10.1038/cdd.2016.134. Epub 2016 Nov 18. Review.

7.

Cytoplasmic gain-of-function mutant p53 contributes to inflammation-associated cancer.

Bellazzo A, Di Minin G, Collavin L.

Mol Cell Oncol. 2015 Jan 23;2(4):e1002719. doi: 10.1080/23723556.2014.1002719. eCollection 2015 Oct-Dec.

8.

Identification of Spen as a Crucial Factor for Xist Function through Forward Genetic Screening in Haploid Embryonic Stem Cells.

Monfort A, Di Minin G, Postlmayr A, Freimann R, Arieti F, Thore S, Wutz A.

Cell Rep. 2015 Jul 28;12(4):554-61. doi: 10.1016/j.celrep.2015.06.067. Epub 2015 Jul 16.

9.

Mutant p53 reprograms TNF signaling in cancer cells through interaction with the tumor suppressor DAB2IP.

Di Minin G, Bellazzo A, Dal Ferro M, Chiaruttini G, Nuzzo S, Bicciato S, Piazza S, Rami D, Bulla R, Sommaggio R, Rosato A, Del Sal G, Collavin L.

Mol Cell. 2014 Dec 4;56(5):617-29. doi: 10.1016/j.molcel.2014.10.013. Epub 2014 Nov 13.

10.

A genome-scale protein interaction profile of Drosophila p53 uncovers additional nodes of the human p53 network.

Lunardi A, Di Minin G, Provero P, Dal Ferro M, Carotti M, Del Sal G, Collavin L.

Proc Natl Acad Sci U S A. 2010 Apr 6;107(14):6322-7. doi: 10.1073/pnas.1002447107. Epub 2010 Mar 22.

11.

The evolutionary conserved gene C16orf35 encodes a nucleo-cytoplasmic protein that interacts with p73.

Lunardi A, Chiacchiera F, D'Este E, Carotti M, Dal Ferro M, Di Minin G, Del Sal G, Collavin L.

Biochem Biophys Res Commun. 2009 Oct 16;388(2):428-33. doi: 10.1016/j.bbrc.2009.08.027. Epub 2009 Aug 8.

PMID:
19666006

Supplemental Content

Loading ...
Support Center